tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Therapeutics: Strong AUVELITY/SUNOSI Momentum and Rich Late-Stage Pipeline Underpin Buy Rating
RatingsAxsome Therapeutics: Strong AUVELITY/SUNOSI Momentum and Rich Late-Stage Pipeline Underpin Buy Rating
19d ago
AXSM
Axsome Therapeutics price target raised to $222 from $219 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $222 from $219 at RBC Capital
20d ago
AXSM
Axsome Therapeutics price target raised to $251 from $248 at UBS
PremiumThe Fly
Axsome Therapeutics price target raised to $251 from $248 at UBS
20d ago
AXSM
Axsome Therapeutics price target raised to $207 from $204 at Morgan Stanley
PremiumThe Fly
Axsome Therapeutics price target raised to $207 from $204 at Morgan Stanley
20d ago
AXSM
Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
PremiumThe Fly
Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
20d ago
AXSM
Axsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
PremiumThe FlyAxsome announces first patient dosed in CLARITY Phase 3 trial of solriamfetol
20d ago
AXSM
Axsome Therapeutics price target raised to $220 from $205 at Guggenheim
Premium
The Fly
Axsome Therapeutics price target raised to $220 from $205 at Guggenheim
20d ago
AXSM
Axsome Therapeutics price target raised to $202 from $193 at Wells Fargo
Premium
The Fly
Axsome Therapeutics price target raised to $202 from $193 at Wells Fargo
20d ago
AXSM
Axsome Therapeutics: Auvelity Growth and Alzheimer’s Agitation Upside Support Buy Rating and $214 Target
PremiumRatings
Axsome Therapeutics: Auvelity Growth and Alzheimer’s Agitation Upside Support Buy Rating and $214 Target
20d ago
AXSM
Axsome Therapeutics Signals Strong Growth in Earnings Call
PremiumCompany Announcements
Axsome Therapeutics Signals Strong Growth in Earnings Call
21d ago
AXSM
Axsome Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe Fly
Axsome Therapeutics initiated with an Outperform at Wolfe Research
21d ago
AXSM
Axsome Therapeutics price target raised to $215 from $195 at TD Cowen
PremiumThe Fly
Axsome Therapeutics price target raised to $215 from $195 at TD Cowen
21d ago
AXSM
Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
PremiumThe FlyMidday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
21d ago
D
DE
Axsome Therapeutics: Buy Rating on Solid Execution, Sufficient Cash Runway, and Advancing Late‑Stage Pipeline
Premium
Ratings
Axsome Therapeutics: Buy Rating on Solid Execution, Sufficient Cash Runway, and Advancing Late‑Stage Pipeline
21d ago
AXSM
Buy Rating on Axsome: Strong Commercial Momentum, Expanding CNS Pipeline, and Attractive Valuation Upside
Premium
Ratings
Buy Rating on Axsome: Strong Commercial Momentum, Expanding CNS Pipeline, and Attractive Valuation Upside
21d ago
AXSM
Axsome Therapeutics reports Q4 EPS (56c), consensus (73c)
PremiumThe Fly
Axsome Therapeutics reports Q4 EPS (56c), consensus (73c)
21d ago
AXSM
Axsome Therapeutics sees cash runway into cash flow positivity
PremiumThe Fly
Axsome Therapeutics sees cash runway into cash flow positivity
21d ago
AXSM
Options Volatility and Implied Earnings Moves Today, February 23, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, February 23, 2026
21d ago
DPZ
OKE
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AXSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
AXSM
Axsome Therapeutics price target raised to $230 from $217 at Mizuho
PremiumThe FlyAxsome Therapeutics price target raised to $230 from $217 at Mizuho
25d ago
AXSM
Axsome Therapeutics: Strengthened Sunosi Exclusivity and Robust Late‑Stage Pipeline Underpin Buy Rating
Premium
Ratings
Axsome Therapeutics: Strengthened Sunosi Exclusivity and Robust Late‑Stage Pipeline Underpin Buy Rating
26d ago
AXSM
Axsome secures long-term SUNOSI exclusivity through Alkem settlement
Premium
Company Announcements
Axsome secures long-term SUNOSI exclusivity through Alkem settlement
27d ago
8K
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >